Abstract:BACKGROUND: S100B is involved in brain injury. This study aimed to determine plasma and cerebral spinal fluid (CSF) levels of S100B in patients with spontaneous intracerebral hemorrhage (ICH), and to correlate S100B levels with Glasgow Coma Scale (GCS) scores, ICH volumes, presence of intraventricular hemorrhage (IVH), and survival rate, and to correlate CSF S100B levels with plasma S100B levels as well as CSF interleukin-1beta (IL-1 beta) levels.METHODS: Ten patients with suspicion of subarachnoid hemorrhage and 38 patients with spontaneous basal ganglia hemorrhage were included in the study. Their plasma and CSF samples were collected. The concentrations of IL-1 beta in CSF and S100B in plasma and CSF were analyzed by enzyme-linked immunosorbent assay.RESULTS: Plasma or CSF S100B levels in the ICH group were significantly higher than those in the control group (178.7 +/- 74.2 versus 63.2 +/- 23.0 pg/ml; P<0.001 or 158.1 +/- 70.9 versus 1.8 +/- 0.7 ng/ml; P<0.001). S100B levels were highly associated with GCS scores, ICH volumes, presence of IVH, and survival rate ( all P<0.05). CSF S100B levels were highly associated with plasma S100B levels as well as CSF IL-1 beta levels (both P<0.01) in patients with ICH. A receiver operating characteristic curve identified CSF and plasma S100B cutoff levels that predicted 1-week mortality of patients with a high sensitivity and specificity. The areas under curves (AUCs) of GCS scores and ICH volumes were larger than those of CSF and plasma S100B levels, but the differences were not statistically significant (P>0.05).CONCLUSION: High levels of S100B are present in the cerebrospinal fluid and peripheral blood of patients with ICH and may contribute to the inflammatory processes of ICH. The levels of CSF and plasma S100B after spontaneous onset of ICH seem to correlate with clinical outcome in these patients. Increases in peripheral S100B properly reflect brain injury, and plasma S100B level may serve as a useful clinical marker for evaluating the prognosis of ICH.

S100b Gene Expression Pattern in Spinal Cords

Expression of S100B Protein Levels in Serum and Cerebrospinal Fluid with Different Forms of Neuropsychiatric Systemic Lupus Erythematosus.

Progress of Ca2+-binding protein S100A12

High S100B Levels in Cerebrospinal Fluid and Peripheral Blood of Patients with Acute Basal Ganglial Hemorrhage Are Associated with Poor Outcome.

S100A6 and Its Brain Ligands in Neurodegenerative Disorders

The S100B story: from biomarker to active factor in neural injury

S100B actions on glial and neuronal cells in the developing brain: an overview

[The Research Progression of S100beta As a Neurochemistry Maker].

Upregulation of S100A4 after Spinal Cord Transectionin Adult Rats

S100B protein: general characteristics and pathophysiological implications in the Central Nervous System

S100A4 in the Physiology and Pathology of the Central and Peripheral Nervous System

Functional expression, characterization, and application of human S100B.

S100 Protein and Brain Injury Induced by Extracorporeal Circulation

Distribution of a specific calcium-binding protein of the S100 protein family, S100A6 (calcyclin), in subpopulations of neurons and glial cells of the adult rat nervous system

Calcium-Dependent Translocation of S100B Is Facilitated by Neurocalcin Delta

Inflammatory role of S100A8/A9 in the central nervous system non-neoplastic diseases

Characterization of the Tissue-Specific Expression of the S100p Gene Which Encodes an Ef-Hand Ca2+-Binding Protein

POSTNATAL DEVELOPMENT OF S100B AND GFAP IN THE CENTRAL NERVOUS SYSTEM IN RATS

Human Neuronal Calcium Sensor-1 Shows the Highest Expression Level in Cerebral Cortex

Proinflammatory S100A9 Regulates Differentiation and Aggregation of Neural Stem Cells

Correlation of serum S100B protein and human anti-brain tissue antibody levels with cognitive function in patients with Alzheimer's disease